KATELYN HOLDER: Open Payments
NPI 1033743299 · SOUTH BOSTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,193 in 63 payments from 13 companies in 2025. Trend: 2023 $529 · 2024 $1,081 · 2025 $1,193
Food & beverage: $1,094Education: $99
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 11 | $184 |
| Otsuka America Pharmaceutical, Inc. | 10 | $149 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $148 |
| Travere Therapeutics, Inc. | 5 | $143 |
| Vifor Pharma, Inc. | 5 | $101 |
| OPKO Pharmaceuticals, LLC | 2 | $99 |
| AstraZeneca Pharmaceuticals LP | 6 | $99 |
| Mallinckrodt Hospital Products Inc. | 4 | $84 |
| Novo Nordisk Inc | 5 | $81 |
| ANI Pharmaceuticals, Inc. | 2 | $51 |
Products named: IBSRELA, JYNARQUE, Kerendia, Veltassa, RAYALDEE, FARXIGA, ACTHAR, Wegovy.
Industry payments across VA — which companies pay providers there.
